EPO and Alzheimer disease: Compared to AD control group, the AH group, the KRG + AH group, the CS group, the KRG + CS group, the EPO group, and the KRG + EPO group showed a significantly decreased severity on the modified SCORAD index (p < 0.001), respectively on day 8.